If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
1,975.00    9.00 (0.46%)
Bid:
1,973.00
Ask:
1,979.00
Spread: 6.00 (0.304%)
Market Cap: £1.31b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

31 Dec 2013 12:41

RNS Number : 6678W
Genus PLC
31 December 2013
 



31 December 2013

 

 

Genus plc

("Genus" or the "Company")

 

Director/PDMR Shareholdings

 

As described in the Genus 2013 Annual Report, following the introduction of compulsory deferral of 25% of annual bonus earned by Executive directors and members of the Genus Executive Leadership Team ("GELT"), in respect of bonuses earned in the financial year ending 30 June 2013, Genus announces that nil cost options were awarded yesterday under the Genus Deferred Share Bonus Plan (the "Plan") to:

 

· Karim Bitar, Chief Executive, as to 3,495 ordinary shares of 10 pence each in the Company ("Shares");

 

· Stephen Wilson, Group Finance Director, as to 1,050 Shares;

 

· Bill Christianson, Chief Operating Officer, Genus PIC, as to 1,132 Shares;

 

· Saskia Korink Romani, Chief Operating Officer, Genus ABS, as to 487 Shares;

 

· Jerry Thompson, Chief Operating Officer, Genus Asia, as to 2,092 Shares; and

 

· Catherine Glickman, Group Human Resources Director, as to 1,014 Shares.

 

 

Subject to the terms of the Plan and the grantee's continued service, the awards will ordinarily vest on 27 September 2016.

 

No consideration was paid for the grant of these awards and no consideration is due in connection with the exercise of these awards.

 

On the same date, in accordance with the terms of joining contained in their respective employment contracts, the following GELT members were granted contingent rights over Shares under individual award agreements as follows:

 

· Saskia Korink Romani, Chief Operating Officer, Genus ABS, as to 2,076 Shares with a normal vesting date of 7 January 2015; and

 

· Jonathan Lightner, Chief Scientific Officer, as to 8,918 Shares with a normal vesting date of 21 October 2014 as to 4,459 Shares and 21 October 2015 as to 4,459 Shares.

 

Subject to the terms of the individual award agreements and the relevant grantee's continued service, the awards will ordinarily vest on the normal vesting date for the awards as specified above.

 

No consideration was paid for the grant of these awards and no consideration is due in connection with the exercise of these awards.

 

This notification is made in accordance with DR 3.1.4R(1)(a).

 

 

 

For further information please contact:

 

Cara Crichton

Deputy Company Secretary

Genus plc

 

Tel: 01256 347100

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUAOUROKAUOAA
Date   Source Headline
28th Feb 20251:30 pmRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSInterim Results
26th Feb 20257:00 amRNSNon-Executive Director Retirement
3rd Feb 20253:17 pmRNSBlock Listing Six Monthly Return
3rd Feb 20259:40 amRNSTotal Voting Rights
15th Jan 20257:00 amRNSHalf Year Trading Update – Ahead of expectations
12th Dec 20245:07 pmRNSNotification of Major Holdings
20th Nov 20243:32 pmRNSResults of AGM
20th Nov 20247:00 amRNSAGM Trading Update
1st Nov 202410:42 amRNSTotal Voting Rights
22nd Oct 20247:00 amRNSChief Financial Officer Retirement
14th Oct 20247:00 amRNSAnnual Report and Annual General Meeting
18th Sep 202411:17 amRNSDirector/PDMR Shareholding
16th Sep 20244:29 pmRNSDirector/PDMR Shareholding
12th Sep 20244:51 pmRNSDirector/PDMR Shareholding
12th Sep 20247:00 amRNSDirector/PDMR Shareholding
9th Sep 20247:00 amRNSDirector/PDMR Shareholding
6th Sep 202412:31 pmRNSDirector/PDMR Shareholding
6th Sep 202412:30 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSPreliminary Results
1st Aug 20244:26 pmRNSBlock Listing Six Monthly Return
1st Aug 20243:38 pmRNSTotal Voting Rights
17th Jul 20247:00 amRNSTrading Update
3rd Jun 202410:48 amRNSHolding(s) in Company
1st May 20241:59 pmRNSTotal Voting Rights
22nd Feb 20247:00 amRNSInterim Results
15th Feb 20247:00 amRNSTrading Update
1st Feb 20244:24 pmRNSBlock listing Interim Review
1st Feb 20244:21 pmRNSTotal Voting Rights
12th Dec 20237:00 amRNSNon-Executive Director Appointment
22nd Nov 20231:08 pmRNSResult of AGM
22nd Nov 20237:00 amRNSAGM Trading Update
1st Nov 20234:46 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSCapital Markets Event
13th Oct 20237:00 amRNSAnnual Report and Annual General Meeting
5th Oct 202310:19 amRNSPos. determination-PRRS resistant pigs-Colombia
2nd Oct 202311:12 amRNSTotal Voting Rights
15th Sep 20231:07 pmRNSDirector/PDMR Shareholding
15th Sep 202310:04 amRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSPreliminary Results
25th Aug 20238:35 amRNSNotification of Major Holdings
23rd Aug 20239:25 amRNSDirectorate Change
1st Aug 202311:41 amRNSBlock listing Interim Review
1st Aug 202311:36 amRNSTotal Voting Rights
3rd Jul 202311:02 amRNSTotal Voting Rights
16th Jun 20235:33 pmRNSNational Milk Records plc - Form 8.3
16th Jun 20235:10 pmRNSForm 8.3 (OPD) - National Milk Records plc
8th Jun 20233:51 pmRNSDirector/PDMR Shareholding
7th Jun 20235:11 pmRNSNotification of Major Holdings
7th Jun 20235:08 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.